77 /100
CRITICAL RISK
Score updated May 29, 2026

HCTI — Healthcare Triangle, Inc. Dilution Risk Tracker

Track HCTI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HCTI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
85
📊 Float Risk
35
⚠️ Warrant Exposure
90
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
48%
📜 Warrant Exercise 60%
• Massive warrant overhang: 70% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise 53%
• Low cash runway: 5 months remaining
• Active ATM program with $33M remaining capacity
🔄 Reverse Split 15%
• Only 5 months cash — financial pressure
🔔 Track HCTI — Get forecast alerts →

💹 Market Data

Market Cap$5.29M
Shares Outstanding2.03M
Float2.03M
Cash$4.32M
Debt$10.87M
Short InterestN/A

🏛 Institutional Holdings

5.5% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track HCTI for full holder detail →

📉 Short Interest

Short Interest157.7K
Days to Cover1.1
% of Float7.8%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Feb 26, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2025
424B5 ATM Mar 31, 2026
424B5 ATM Feb 27, 2026
8-K 8K EVENT Feb 27, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track HCTI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HCTI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: BTBT LBSR STKH VELO ZSPC
🔬 More Research for HCTI
📊 HCTI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HCTI Signal Convergence & Dark Pool Activity — StonkWhisper 📄 HCTI Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.